Scarlatti, G, Hodara V, Rossi P, Muggiasca L, Bucceri A, Albert J, Fenyo EM. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother to child correlates with viral phenotype. Virology 197(2):624-629, 1993.
Schoen EJ. Northern California Kaiser Permanente Health Plan. Personal communication, 1998.
Scott R. Sickle-cell anemia, high prevalence and low priority. N Engl J Med 282:164-165, 1970.
Segal AI. Physician attitudes toward human immunodeficiency virus testing in pregnancy. Am J Obstet Gynecol 174(6):1750-1756, 1996.
Semba RD, Miotti P, Chiphangwi JD, Saah AJ, Canner JK, Dallabetta GA, Hoover DR. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343:1593-1597, 1994.
Shakarishvili A, Schulte J, Levine W, Kreitner S, Caldwell B, St. Louis M. Lack of timely prenatal care among women infected with HIV: Implications for prevention of perinatal HIV transmission in the United States. Abstract presented at the Eleventh International Conference on AIDS, Vancouver, BC, July 7-12, 1996. [www document] URL http://sis.nlm.nih.gov/aidsabs.htm
Siegel K, Gorey E. HIV-infected women: Barriers to AZT use. Soc Sci Med 45(1):15-22, 1997.
Silverman NS, Rohner DM, Turner BJ. Attitudes toward health-care, HIV infection, and perinatal transmission interventions in a cohort of inner-city, pregnant women. Am J Prenatal 14(6):341-346, 1997.
Simonds RJ, Rogers M. Impact of the PHS voluntary testing recommendations. Results from CDC's surveillance and enhanced surveillance systems. Presentation at IOM Workshop on Perinatal Transmission of HIV, Washington DC, April 1, 1998.
Simpson JL, Nadler HL. Maternal serum alpha-fetoprotein screening in 1987. Obstet Gynecol 69:134-134, 1987.
Simpson W, Hart G, Johnston FD, Goldberg DJ, Boyd FM. Comparison of opt-in and opt-out HIV testing in antenatal care: uptake and acceptability in Edinburgh, Scotland [abstract #43120]. Abstract presented at the Twelfth World AIDS Conference, Geneva, Switzerland. June 28-July 3, 1998.
Sperling RS, Shapiro DE, Coombs RW, Todd LA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study group. N Engl J Med 335(22):1621-1629, 1996.
Sprecher S, Soumenkoff G, Puissant F, Degueldre MD. Vertical transmission of HIV in 15 week fetus. Lancet 2:288-289, 1986.
Stoddard T, Reiman W. AIDS and the rights of the individual: Toward a more sophisticated understanding of discrimination. Milbank Q 68 (Suppl 1):143-174, 1990.
Study EC. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics 94:815-819, 1994.
Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, Matheson PB, Abrams EJ, Bamji M, Lambert G, Schoenbaum EA, Thomas PA, Heagarty M, Kalish ML. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS 11(4):437-444, 1997.
Thomas S, Quinn S. Presidential apology for the Study at Tuskegee (1997). 1998 Medical and Health Annual. Chicago, IL: Encyclopedia Britannica, 280-281, 1997.
Turner BJ, Markson L, Hauck W, Cocroft J, Fanning T. Prenatal care of HIV-infected women: Analysis of a large New York State cohort. J Acquir Immune Defic Syndr Hum Retrovirol 9(4):371-378, 1995.
Turner BJ, McKee-Nelsen L, Fanning TR, Hauck WW. Prevention of vertical HIV transmission with zidovudine: Projected impact of HIV testing and prenatal care. AIDS Care 9(5):577-588, 1997.
U.S. Public Health Service (USPHS). Syphilis in Mother and Child. Supplement 7 to Venereal Disease Information (Washington, DC: Government Printing Office, 1940), 1.
Urban Institute. Counting the Uninsured: A Review of the Literature. Occasional Paper No. 8. 1998.